Figure A2.

(A) NDUFS1 mRNA expression levels in prostate cancer patients, analyzed from primary PCa (n = 10) and metastasis (n = 4; 3.00-fold increase). (B) ATP5O mRNA expression levels in prostate cancer patients, analyzed from primary PCa (n = 8) and metastasis (n = 3; 1.75-fold increase). Data were extracted from the Oncomine™ Platform from the (A) Ramaswamy Multi-cancer and (B) Magee Prostate datasets. Representation: boxes as interquartile range, horizontal line as the mean, whiskers as lower and upper limits.